Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
2008-2009 Accomplishments -Project 2 Mark Noble, PhD
INTRODUCTION: A wide range of evidence demonstrates that children with autism or autism spectrum disorders (ASD), and also parents of these children, frequently have abnormalities in their redox status that render them more oxidized. Increased levels of oxidized glutathione, as well as other indications of a more oxidized state, have been observed in plasma, serum and urine samples from individuals diagnosed with ASD (Chauhan and Chauhan, 2006; Chauhan et al., 2004; James et al., 2004; James et al., 2006; Ming et al., 2005; Pasca et al., 2006; Sogut et al., 2003; Yorbik et al., 2002; Zoroglu et al., 2004) . The prevalence redox abnormalities far exceeds the prevalence of individual mutations that have been associated with ASD (e.g, mutations in the homeobox transcription factor engrailed-2 (Bartlett et al., 2005; Benayed et al., 2005) , protein kinase C-beta (Philippi et al., 2005) , ataxin-2 binding protein-1 (A2BP1, also referred to as FOX1 (Martin et al., 2007) ), glutamate receptor 6 (Jamain et al., 2002) , methyl-CpG-binding protein 2 (MECP2, which causes Rett syndrome (Shibayama et al., 2004) , the mitochondrial aspartate/glutamate carrier (AGC1) (Ramoz et al., 2004) , reelin protein (Bartlett et al., 2005; Fatemi et al., 2005; Serajee et al., 2006; Skaar et al., 2005 ) the promoter region of the c-Met gene (Campbell et al., 2006) ). Such a prevalence indicated that increased oxidative status a feature of ASD that is common to multiple genotypes. A more oxidized phenotype would in and of itself be predicted to alter developmental processes and to increase vulnerability to physiological stressors. It is of particular interest in this context that small changes in redox state may have disproportionately large effects on cellular function. Our previous studies have shown that altering glutathione content by as little is 15% is sufficient to greatly increase the vulnerability of neural progenitor cells and neurons to physiological stressors and exposure to suboptimal levels of trophic factors required for cell survival and to alter the response to normal regulators of progenitor cell differentiation . For example, a 15% increase in glutathione content is sufficient to cause a 1300% increase in the number of surviving neurons in neuronal cultures exposed to sub-optimal amounts of nerve growth factor. The overall objectives of this research effort are (i) to understand the relationship between altered redox function in children with ASD and the neuropathological changes found in this children, (ii) to provide enhanced means of studying these redox abnormalities and of identifying children who may be more vulnerable to physiological stressors of putative relevance to ASD and (iii) to provide rational approaches to the effective normalization of these metabolic parameters. Project 2 is focused on the hypotheses that redox abnormalities in cells of the hematopoietic system are predictive of redox abnormalities in the CNS, that these abnormalities cause oligodendrocyte progenitor cells to differentiate earlier in development (with subsequent loss of progenitor cells) and that such abnormalities also increase the vulnerability of these progenitor cells to physiological stressors thought to be relevant to ASD pathogenesis. The central question of Aim 1 is to develop better means of identifying cells with different basal redox states. To address this question it is critical to identify a range of redox-related criteria that can be applied to this analysis, so as not to make it dependent upon measurement of single parameters.
KEY RESEARCH ACCOMPLISHMENTS
• In our work thus far we have first tried to address the problem that train differences may themselves provide differences between cell populations that may or may not be relevant to redox status. Therefore we have focused on goals 1e and 1f in order to first broaden the parameters that will be applied to the populations of 1b and 1c. We have taken advantage of an opportunity afforded by our developmental studies showing that the glial progenitor cells that give rise to oligodendrocytes isolated from different regions of the CNS of the same animals have different intrinsic redox states. (These cells are referred to in the literature as oligodendrocyte/type-2 astrocyte progenitor cells and also as oligodendrocyte precursor cells, and here abbreviated as O-2A/OPCs) This is an ideal situation in which to define redoxrelated differences in metabolite and protein expression without concern about differences that might be due to strain differences but unrelated to redox status.
We now have defined a markedly increased range of redox-associated parameters applicable to our further studies. Based on the observations that cortical and corpus callosum O-2A/OPCs exhibit different intracellular redox states, we investigated the physiological basis for these differences. We found multiple differences between cortical and callosal O-2A/OPCs that appear relevant to the differences in redox state between these two cell populations.
• Cortical cells have ~2-fold higher levels of reduced thiols, as determined by labeling with monochlorobimane (MCB) (Fig. 1A) . As glutathione is the major reduced thiol in cells, MCB is often used as an indicator of glutathione content (Sun et al., 2005) . In agreement with this, cortical O-2A/OPCs also have 80% higher levels of -glutamyl-cysteinyl-synthase heavy chain ( -GCS) (Fig. 1B, C) , the rate-limiting enzyme in glutathione biosynthesis (Deneke and Fanburg, 1989) . Fluorescence analysis also revealed that corpus callosumderived O-2A/OPCs had lower levels of NADH and NAD(P)H, as compared with cortex-derived cells as determined by analysis of autofluoresence elicited with an argon laser (488 nm) and multiline ultraviolet light ( Figure 1D ) (Petit et al., 2001 ).
• Examination of other proteins known to be associated with cells being more reduced revealed higher levels of bcl-2, the mitochondrial superoxide dismutase (SOD)-1, but not the cytoplasmic SOD-2 or catalase ( Figure 2 ). In particular bcl-2 levels were nearly 4 times higher in cortical cells than in corpus callosum progenitors.
• Our studies also suggest that the mitochondria of cortical O-2A/OPCs may be functionally more active than those in corpus callosum cells. We found that cortical cells have ~20% higher levels of free calcium (as detected by Fura-Red labeling) and also found that cortical progenitors exhibit a 2.5 times higher ADP:ATP ratios than corpus callosum-derived progenitors ( Figure 3 ). Both of these differences are associated with increased mitochondrial activity (Civelek et al., 1996; Gunter et al., 2000) , consistent with our analysis with the dye JC-1 that indicates mitochondria in more reduced O-2A/OPCs are more depolarized than those in more oxidized O-2A/OPCs . As for Aim 1, we have taken advantage of the redox differences in O-2A/OPCs from different regions of the developing CNS to examine vulnerability of cells to physiological stressors, thus defining the issues of Aim 2d in a manner that is more likely to be due to redox differences than to other strain differences. Our results showed that O-2A/OPCs from the cortex (which are more reduced) are less vulnerable to physiological stressors than those from the corpus callosum. We also found, however, that cells of the corpus callosum were heterogeneous in their response to physiological stressors. We therefore focused in greater detail on this population to determine if this heterogeneity in vulnerability to stressors was associated with redox differences and was itself regulated by these redox differences. In order to address one of the specific physiological stressors that has been shown to be elevated in the cerebrospinal fluid of children with autism, we have focused our attention on tumor necrosis factor-alpha (TNF--). This protein is produced as part of the inflammatory response, and has long been known to be toxic for oligodendrocyte, the myelin-forming cells of the CNS (which themselves have been suggested to undergo abnormal development in the CNS of children with autism, based on abnormal patterns of myelination seen in these children).
Focusing attention on oligodendrocytes has also enabled us to examine the question of whether a difference in redox status in progenitor cells causes differences in the vulnerability of the differentiated cells they generate. The idea that the metabolic status of a precursor cell may alter the vulnerability of the differentiated cells derived from that precursor cell appears to be a new concept, and supports the hypothesis that redox status may affect cellular function in multiple ways of potential relevant to the pathophysiology of autism spectrum disorders.
• Heritable vulnerability: The vulnerability of oligodendrocytes to physiological stressors is based on the redox state of their parental O-2A/OPCs
Virtually nothing is known about the biological underpinnings of differential vulnerability within a population of putatively identical cells. This heterogeneity could represent a truly random dispersion of outcomes in a cellular population, but it is also possible that the seemingly stochastic distribution of outcomes is reflective of identifiable biological differences between surviving and vulnerable cells.
• Vulnerability to TNF-is not randomly distributed: When we examined oligodendrocyte vulnerability to TNF-at the clonal level, we found the extent of cell death was nonrandomly distributed according to the size of a clone in which an oligodendrocyte was generated Figure 4) . Clones in which >50% of oligodendrocytes were killed by exposure to 20 ng/ml TNF-all contained <40 total cells, while in 14/17 clones with >20 cells the majority of oligodendrocytes were not killed by TNF-.
The discovery that TNF-vulnerability correlates with clonal size raises the possibility that these two characteristics are physiologically related to each other. Our previous studies demonstrated a direct correlation between the intracellular redox state of a progenitor cell and the extent of division occurring in the clone derived from that cell, suggesting a possible explanation for our observations.
• Vulnerability of oligodendrocytes to TNF-and glutamate correlates with the intracellular redox state of their ancestral progenitor cell: We next tested the possibility that the intracellular redox state of a progenitor cell was predictive of the vulnerability of the differentiated cell it generates, applying our previous protocols for purifying O-2A/OPCs on the basis of this physiological state. DHCM-Rosamine low progenitors (i.e., those that were more reduced at the time of isolation) gave rise to oligodendrocytes that were resistant to killing by TNF-, and also were relatively resistant to the background death of oligodendrocytes that normally occurs in these cultures ( . CC progenitor cells were plated at clonal densities and allowed to differentiate into oligodendrocytes. Clones were treated with TNF at 20ng/ml and the % of live oligodendrocytes in each clone was scored using MTT and DAPI as indicators.
Figure 5: CC derived progenitor cells were separated into rosamine high and rosamine low population using FACS sorting. Oligodendrocytes generated from these two populations were treated with TNF alpha at various doses and the % of live cells was determine using the MTT assay and DAPI staining. Oligodendrocytes derived from the Rosamine low (= more reduced) progenitor cells were significantly less sensitive to TNFthan cells derived from Rosamine high progenitor populations.
TNF-had no effect on these cultures, in which viability remained 20% above control values. In striking contrast, DHCM-Rosamine high progenitor cells (i.e, those that were more oxidized at the time of isolation) were vulnerable to TNF-, with exposure to 10ng/ml TNF-reducing cell viability by 40% and 20ng/ml reducing viability by 60%. The correlation of progenitor cell redox state with oligodendrocyte vulnerability was not restricted to TNF-, but was also observed for vulnerability of oligodendrocytes to glutamatemediated toxicity (data not shown).
• Pharmacological manipulation of progenitor cell redox state alters vulnerability to TNF-and glutamate of the oligodendrocytes they generate: Transient pharmacological manipulation of O-2A/OPC redox state prior to the induction of differentiation indicated the relationship of redox state between progenitor and oligodendrocyte was causally relevant to differences in oligodendrocyte vulnerability to physiological stress. To make O-2A/OPCs more oxidized, we exposed them for 48 hrs to buthionine sulfoximine (BSO, which inhibits glutathione biosynthesis) or to 1mM NAC to make cells more reduced. Cells then were washed and medium containing the compound used to manipulate intracellular redox state was replaced with fresh medium prior to the induction of oligodendrocyte generation. All cultures were exposed to TH for 96 hrs to induce differentiation into oligodendrocytes, after which sensitivity to TNF-or glutamate was determined. As shown in Figure 6A , O-2A/OPCs exposed to BSO generated oligodendrocytes that were more vulnerable to killing by TNF-, as compared with untreated cells. Similar results were obtained for glutamate, another physiological stressor that is present at elevated levels when inflammation occurs in the CNS. In contrast, exposure of O-2A/OPCs to 1mM NAC for 48 hrs, followed by induction of oligodendrocyte generation with TH, conferred protection against both glutamate ( Figure 6B ) and TNF-(not shown). For example, in control cultures, a significant reduction in cell numbers was seen following exposure to as little as 0.1 mM glutamate, with killing of >60% of cells occurring at glutamate concentrations of 10 mM. In contrast, oligodendrocytes derived from O-2A/OPCs grown transiently in the presence of NAC were not killed at all by 10mM glutamate. Glutamate concentrations of 100mM were required to override the protective effects conferred by transient exposure to NAC prior to the induction of differentiation.
Reportable outcomes: None

Conclusions: Our studies have thus far defined multiple parameters related to differences in cellular redox status and have demonstrated that the redox status of a precursor cell is so important in controlling vulnerability to physiological stressors that it even regulates the vulnerability of the differentiated cell types that it generates.
This work now provides an expanded basis for our analysis of strain differences, allowing us to distinguish between changes that correlate with differences in redox status in a manner that is not strain dependent and those changes that may reflect genetic differences between strains. While the latter differences are important to also identify, our present discoveries will make it more efficient to identify differences that are not unique to particular strains and instead have the potential of being of general utility. Deliverables: We anticipate 2 publications in major peer-reviewed journals that integrate our present findings with studies on strain differences. In addition, we will analyze the cell lines from autistic children being analyzed in Project 1 in order to obtain information on these additional parameters. The identification of changes in multiple metabolites also provides new targets of potential interest for the methodologies being provided by Project 3. In addition, in the next stage of our analysis we will integrate qnalysis of mechanistic contributions of redox/Fyn/c-Cbl pathway activation to biological outcomes, which may additional parameters of use in defining differences in redox status and also will provide new therapeutic targets for analysis of restoration of normal function and for intervention to protect individuals with vulnerability phenotypes.
Problems encountered and solutions:
The major challenge encountered in this portion of our work was in distinguishing strain differences related to redox state from other differences that may represent strain differences that are not generally important in redox state analysis. By focusing analysis on populations that have intrinsic differences in redox status but do not differ genetically we have identified multiple parameters, and also differences in vulnerability to physiological stressors, that cannot be attributed to strain differences that may be irrelevant to achieving our goals. Thus, we have defined a variety of parameters and outcomes related to redox differences in different cellular populations that can now be applied to analysis of strain differences focused on redox parameters. Zoroglu, S. S., Armutcu, F., Ozen, S., Gurel, A., Sivasli, E., Yetkin, O., Meram, I., 2004 
